리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 06월
페이지 정보:영문 94 Pages
라이선스 & 가격 (부가세 별도)
한글목차
헌터증후군 치료(Hunter Syndrome Treatment) 시장은 2030년까지 17억 달러에 이를 전망
2023년에 12억 달러로 추정된 헌터증후군 치료 시장은 2030년에는 17억 달러에 달할 것으로 예상되며, 분석 기간 2023-2030년의 CAGR은 5.7%로 성장할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 효소 보충 요법(ERT)은 CAGR 6%로 성장을 지속하고, 분석 기간 종료 시에는 14억 달러에 달할 것으로 예측됩니다. 조혈 줄기세포 이식(HSCT) 분야의 성장은 향후 7년간의 CAGR이 4.5%로 추정됩니다.
미국 시장은 3억 370만 달러로 추정, 중국은 CAGR 8.9%로 성장 예측
미국 헌터증후군 치료 시장은 2023년 3억 370달러로 추정되었습니다. 세계 2위 경제대국인 중국은 2023년부터 2030년까지 분석 기간 동안 CAGR 8.9%로 성장을 지속하여 2030년에는 3억 9,940만 달러 규모에 이를 것으로 예측됩니다. 다른 주목할만한 지리적 시장으로는 일본과 캐나다가 있으며, 각각 2023-2030년 사이 3.2%와 4.5%의 성장이 예측됩니다. 유럽에서는 독일이 CAGR 약 3.9%로 성장할 것으로 예측됩니다. 호주, 인도, 한국 등 국가들이 견인하는 아시아 태평양 시장은 2030년까지 2억 4,220만 달러에 이를 것으로 예측됩니다.
2024년을 위한 새로운 보고서의 특징
인플루언서의 참여 통계에 대한 전체 액세스 권한
디지털 아카이브와 'MarketGlass' 리서치 플랫폼에 대한 무료 액세스 가능합니다. 당사의 고유한 MarketGlass 플랫폼은 전 세계 전문가의 창의성과 시장 지식을 통합적이고 협업적으로 제공합니다. 당사의 최첨단 도구는 참가자의 프라이버시와 정체성을 보호하면서 세계 수준 시장 전망을 제공합니다. 이 보고서에 게재된 숫자, 통계 및 시장에 대한 설명은 이 분야의 전문가 및 인플루언서가 공유하는 완전한 검토 통찰력을 기반으로 합니다.
실시간 데이터 시뮬레이터 도구와 맞춤형 보고 기능을 갖춘 대화형 설문조사에 참여할 수 있습니다.
기업간의 스마트한 의견 교환을 위한 피어 콜라보레이티브 인터랙티브 플랫폼에 대한 전체 클라이언트 액세스 권한 제공
1년간의 무료 보고서 업데이트
주요 기업 시장 점유율을 포함한 경쟁 적용 범위
복수의 지역에 걸치는 기업 시장 프레즌스 분석(강세/활발/틈새/미미)
전문가/인플루언서 인터뷰, 팟캐스트, 프레스 발표, 이벤트 기조 강연의 YouTube 동영상에 대한 액세스
2024년 세계경제에 기대
금융 계약과 그에 따른 금리 상승으로 인한 지정학적 영향과 경제적 불안정은 2024년 세계 경제를 파란으로 가득 찬 것으로 보입니다. 중동의 적대 행위와 점점 더 자주 발생하는 기후 재해와 같은 몇 가지 요인이 회복의 길에 압력을 가할 것입니다. 위험에 반해, 디스플레이션의 징후가 강해지고, 완고한 인플레이션에 대한 불안이 완화되고, 공급 체인이 정상화되고, 에너지 비용의 변동에도 불구하고 물가가 완만해지는 등, 몇 가지 플러스 재료도 구체화 계속 있습니다. 인도와 미국을 포함한 G21 국가의 선거는 자본 흐름과 투자 전략에 영향을 줄 수 있습니다. 인도가 세계적인 투자처로 주목받고 있는 한편, 미국을 거점으로 하는 하이테크 기업은 재능과 자본의 역동적인 에코시스템에 힘입어 계속 우위를 유지할 것으로 보입니다. 실리콘밸리를 비롯한 하이테크 기회는 국내 경제가 감속하고 있다고는 해도 견고하고 규제 환경도 정비되어 있기 때문에 고성장 가능성을 요구하는 투자자에게 계속 매력적입니다. 유럽은 금융 계약 정책과 경기 후퇴 위험과의 싸움이 계속되고 있지만 영국은 전망이 가장 엄격하고 2024년경기 후퇴 위험이 가장 높습니다. 중국은 정부 지출과 개인 소비 개선에 뒷받침된 성장이 기대되는 것, 계속 와일드카드가 됩니다. 불안정한 환경은 투자자와 기업 모두에게 기회와 도전을 가져올 것으로 보입니다. 성장에 대한 촉매로서 변동성을 받아들이는 것과 동시에 민첩성과 전략적 선견지명과 함께 투자 판단에 임하는 것이 생존을 위해 여전히 중요할 것입니다.
조사 대상 기업 예(전 43건)
ArmaGen, Inc.
Bioasis Technologies, Inc.
BioMarin Pharmaceutical, Inc
Canbridge Life Sciences Ltd.
Denali Therapeutics, Inc
GC Pharma
Genzyme
Green Cross Corp.
Inventiva SA
JCR Pharmaceuticals Co., Ltd.
RegenxBio, Inc.
Sangamo Therapeutics, Inc.
Shrine Plc
Takeda Pharmaceutical Company
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향 및 촉진요인
시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아 태평양
호주
인도
한국
기타 아시아 태평양
남미
아르헨티나
브라질
멕시코
기타 남미
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LYJ
영문 목차
영문목차
Global Hunter Syndrome Treatment Market to Reach $1.7 Billion by 2030
The global market for Hunter Syndrome Treatment estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Enzyme Replacement Therapy (ERT), one of the segments analyzed in the report, is expected to record a 6% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Hematopoietic Stem Cell Transplant (HSCT) segment is estimated at 4.5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $303.7 Million, While China is Forecast to Grow at 8.9% CAGR
The Hunter Syndrome Treatment market in the U.S. is estimated at US$303.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$399.4 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 4.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$242.2 Million by the year 2030.
Introducing Our Exciting New Report Features for 2024
Full access to influencer engagement stats
Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
Select Competitors (Total 43 Featured) -
ArmaGen, Inc.
Bioasis Technologies, Inc.
BioMarin Pharmaceutical, Inc
Canbridge Life Sciences Ltd.
Denali Therapeutics, Inc
GC Pharma
Genzyme
Green Cross Corp.
Inventiva S.A.
JCR Pharmaceuticals Co., Ltd.
RegenxBio, Inc.
Sangamo Therapeutics, Inc.
Shrine Plc
Takeda Pharmaceutical Company
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Hunter Syndrome Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Hunter Syndrome Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Hunter Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Enzyme Replacement Therapy (ERT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Enzyme Replacement Therapy (ERT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Enzyme Replacement Therapy (ERT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Hematopoietic Stem Cell Transplant (HSCT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Hematopoietic Stem Cell Transplant (HSCT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Hematopoietic Stem Cell Transplant (HSCT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Hunter Syndrome Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Hunter Syndrome Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Hunter Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Hunter Syndrome Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Hunter Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 113: India Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Hunter Syndrome Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Hunter Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Hunter Syndrome Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Hunter Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Hunter Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Hunter Syndrome Treatment by Treatment Type - Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Hunter Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Enzyme Replacement Therapy (ERT), Hematopoietic Stem Cell Transplant (HSCT) and Other Treatment Types for the Years 2014, 2024 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Hunter Syndrome Treatment by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for Hunter Syndrome Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2024 & 2030